< Raising the Bar in Pediatric Healthcare 

Cancer and Blood Disorders Outcomes

By the Numbers

* "By the Numbers" data for January 1, 2022 - December 31, 2022, in line with the last U.S. News and World Report Survey 

  • Arkansas Children’s Cancer & Blood Disorders team sees an average of 11,000 appointments yearly. 
  • Provides cancer or blood disorders care to over 250 patients at any given time. 
  • Performed 7 Chimeric Antigen Receptor (CAR) T-cell infusions 
  • Performed 8 autologous and 8 allogeneic stem cell transplants, including with mis-matched donors 
alt=

Awards and Achievements

    Best Children's Hospitals - US News & World Report - Cancer 
  • 2023-2024 USNWR ranking
  • FACT accredited autologous and stem cell collection
  • Modern therapies, CAR-T and photopheresis
  • DA-approved gene therapy
  • Children’s Oncology Group (COG) member
  • Early Phase Clinical Trials Through POETIC, Beat Childhood Cancer and industry partnerships
  • Certified Chimeric Antigen Receptor (CAR) T-Cell Therapy Center   
  • The THRIVE Clinic, a survivorship program, offers a multidisciplinary support team to coordinate visits and decrease disruption of newfound normalcy for up to 10 years post-treatment.       
  • Becker’s list of 100 hospitals and health systems with great oncology programs | 2023 

Cancer and Blood Disorders Service Chief

David Becton, M.D."I practice here because I know my patients will get the best care possible, with tremendous support from our entire team, with compassion, expertise and an emphasis on safety."

David Becton, M.D.  
Pediatric hematologist/oncologist, Arkansas Children’s Hospital 
Chief of pediatric hematology and oncology 
Lawrence H. Schmieding Chair in pediatric hematology-oncology 
Professor of pediatrics, University of Arkansas for Medical Sciences 

 

 

Historia de un paciente

Meet Hewitt

10-year-old fights rare, malignant cancer with compassion, confidence. 

Read Hewitt's story

Contenido relacionado